NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cardiawave

Cardiawave

Private
Levallois-PerretHealthcare & Life Scienceshttps://cardiawave.com/

Last Round

Crowdfunding

Jun 30, 2026

Est. Valuation

$27.22M

Total Funding Raised

$26.01M

Company Overview

Cardiawave is a medical devices company that has developed Valvosoft®, a non-invasive focused ultrasound therapy medical device for the treatment of calcific Aortic Stenosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B2C

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

non-invasive ultrasound therapyNIUTcalcific aortic stenosisaortic stenosis treatmenthigh-intensity focused ultrasoundHIFUfocused ultrasoundTAVR alternativenon-invasive valve repairstructural heart diseaseheart valve diseasetherapeutic ultrasoundcardiology devicereal-time image guidanceCE marked device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiawave Comps

Public and private peers based on sector, stage, and business model.

Cardiawave comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cardiawave Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJun 30, 2026
Series BOct 1, 2020
Series ASep 27, 2018
GrantJun 15, 2018
SeedMar 1, 2017
Seed
Dec 31, 2015

Key People

Founding team and executive leadership

Carine Schorochoff

CEO and Board Director

Executive Team

Maurice Delplanque

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 72% MoM, reaching 1.3K.

  • May 4, 2025

    Monthly visitors increased 69% MoM, from 308 to 520.

Cardiawave Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cardiawave Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cardiawave's valuation, stock price, and market status.

Firmographic Details

HeadquartersLevallois-Perret
Employee Range27
Year Founded2014
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.